Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reappearance of vanished bile ducts.
Chamuleau RA, Diekman MJ, Bos PJ, Smitt JH, Bosma A, Schellekens PT. Chamuleau RA, et al. Among authors: schellekens pt. Hepatogastroenterology. 1992 Dec;39(6):523-4. Hepatogastroenterology. 1992. PMID: 1483665
Guidelines for the optimal use of muromonab CD3 in transplantation.
ten Berge IJ, Parlevliet KJ, Raasveld MH, Buysmann S, Bemelman FJ, Schellekens PT. ten Berge IJ, et al. Among authors: schellekens pt. BioDrugs. 1999 Apr;11(4):277-84. doi: 10.2165/00063030-199911040-00006. BioDrugs. 1999. PMID: 18031137
Memory functions in prednisone-treated kidney transplant patients.
Bermond B, Surachno S, Lok A, ten Berge IJ, Plasmans B, Kox C, Schuller E, Schellekens PT, Hamel R. Bermond B, et al. Among authors: schellekens pt. Clin Transplant. 2005 Aug;19(4):512-7. doi: 10.1111/j.1399-0012.2005.00376.x. Clin Transplant. 2005. PMID: 16008597
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.
Meijer RT, Surachno S, Yong SL, Bemelman FJ, Florquin S, Ten Berge IJ, Schellekens PT. Meijer RT, et al. Among authors: schellekens pt. Clin Exp Immunol. 2003 Sep;133(3):485-92. doi: 10.1046/j.1365-2249.2003.02200.x. Clin Exp Immunol. 2003. PMID: 12930378 Free PMC article. Clinical Trial.
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.
Eijkhout HW, van Der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA, Strengers PF, Nienhuis H, Schellekens PT; Inter-University Working Party for the Study of Immune Deficiencies. Eijkhout HW, et al. Among authors: schellekens pt. Ann Intern Med. 2001 Aug 7;135(3):165-74. doi: 10.7326/0003-4819-135-3-200108070-00008. Ann Intern Med. 2001. PMID: 11487483 Clinical Trial.
167 results